GlassScriptPhysician profile
William G Morice
NPI 1275512691
$9,297.73
in general payments reported to CMS, 2019-2025
5 companies · $3,256 in 2025
The $3,256 reported for 2025 was more than what 92% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,340 · 2021: $92.43 · 2022: $1,066 · 2024: $544 · 2025: $3,256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,506 · Food and Beverage: $250 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,506.07 |
| Food and Beverage | $250.23 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $4,779.47 | 2022-2025 | Iscan Coreo |
| Actelion Pharmaceuticals, LTD | $4,340.00 | 2019 | |
| Roche Molecular Systems, INC. | $92.43 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $43.25 | 2025 | Enhertu |
| Exact Sciences Corporation | $42.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Morice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.